Lumena Pharmaceuticals' Debt Round

Lumena Pharmaceuticals raised a round of funding on May 24, 2012. Investors include Pappas Ventures.

Lumena Pharmaceuticals is developing oral therapeutics for rare liver diseases to improve liver function, relieve disease symptoms and dramatically impact patient health. The company's clinical-stage …

Articles about Lumena Pharmaceuticals' Debt Round: